Home›Search›Antibody Therapeutics

Antibody Therapeutics

Oxford University Press · United States · Est. 2011

ISSN2516-4236eISSN2516-4236

SJR Q2✓ WOS ESCI✓ Scopus / SJR✓ DOAJ✓ Open Access

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 50% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

1.003

H-Indexi

SNIPi

1.164

Total Worksi

263

Total Citationsi

3,414

2yr Mean Citednessi

2.64

Open Impact Factor alternative

Aims & Scope✦ Compiled from public sources

Antibody Therapeutics is a peer-reviewed, online, open access journal that publishes advances and challenges in the discovery and mechanisms of action of antibodies. It aims to deepen understanding of antibody-related areas and accelerate their translation into practice.

AI-compiled from public web sources · verify on publisher page →

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published2011

FrequencyQuarterly

StatusActive (last: 2026)

Total Publications263

Publisher OrgOxford University Press

OA Since2017

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

OA LicenseCC BY, CC BY-NC

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

Portico

Think.Check.Submit Compliance

thinkchecksubmit.org

10/11 · 91%

✅

Do you know the journal / publisher?

Oxford University Press

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2516-4236 / 2516-4236

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

173

2019

935

2020

699

2021

683

2022

362

2023

177

2024

141

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

ImmunologyQ2

Immunology and AllergyQ2

Subject Classification

Web of Science Categories

Immunology

Scopus Categories

ImmunologyImmunology and Allergy

Research Topics (OpenAlex)

Monoclonal and Polyclonal Antibodies ResearchCAR-T cell therapy researchProtein purification and stabilityHER2/EGFR in Cancer ResearchSARS-CoV-2 and COVID-19 ResearchGlycosylation and Glycoproteins ResearchImmunotherapy and Immune ResponsesViral Infectious Diseases and Gene Expression in Insectsvaccines and immunoinformatics approachesTransgenic Plants and Applications

Frequently asked questions about Antibody Therapeutics

Is Antibody Therapeutics a predatory journal?

PubScope has no integrity flags on record for Antibody Therapeutics: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Antibody Therapeutics?

Antibody Therapeutics is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.64.

Is Antibody Therapeutics indexed in Scopus and Web of Science?

Antibody Therapeutics is indexed in Web of Science, Scopus, DOAJ.